These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12396918)

  • 1. Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001.
    Tan CG; Sandhu HS; Crawford DC; Redd SC; Beach MJ; Buehler JW; Bresnitz EA; Pinner RW; Bell BP; ;
    Emerg Infect Dis; 2002 Oct; 8(10):1073-7. PubMed ID: 12396918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001.
    Greene CM; Reefhuis J; Tan C; Fiore AE; Goldstein S; Beach MJ; Redd SC; Valiante D; Burr G; Buehler J; Pinner RW; Bresnitz E; Bell BP;
    Emerg Infect Dis; 2002 Oct; 8(10):1048-55. PubMed ID: 12396914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001.
    Williams AA; Parashar UD; Stoica A; Ridzon R; Kirschke DL; Meyer RF; McClellan J; Fischer M; Nelson R; Cartter M; Hadler JL; Jernigan JA; Mast EE; Swerdlow DL;
    Emerg Infect Dis; 2002 Oct; 8(10):1078-82. PubMed ID: 12396919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center.
    Sanderson WT; Stoddard RR; Echt AS; Piacitelli CA; Kim D; Horan J; Davies MM; McCleery RE; Muller P; Schnorr TM; Ward EM; Hales TR
    J Appl Microbiol; 2004; 96(5):1048-56. PubMed ID: 15078521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
    Jernigan DB; Raghunathan PL; Bell BP; Brechner R; Bresnitz EA; Butler JC; Cetron M; Cohen M; Doyle T; Fischer M; Greene C; Griffith KS; Guarner J; Hadler JL; Hayslett JA; Meyer R; Petersen LR; Phillips M; Pinner R; Popovic T; Quinn CP; Reefhuis J; Reissman D; Rosenstein N; Schuchat A; Shieh WJ; Siegal L; Swerdlow DL; Tenover FC; Traeger M; Ward JW; Weisfuse I; Wiersma S; Yeskey K; Zaki S; Ashford DA; Perkins BA; Ostroff S; Hughes J; Fleming D; Koplan JP; Gerberding JL;
    Emerg Infect Dis; 2002 Oct; 8(10):1019-28. PubMed ID: 12396909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated case of bioterrorism-related inhalational anthrax, New York City, 2001.
    Holtz TH; Ackelsberg J; Kool JL; Rosselli R; Marfin A; Matte T; Beatrice ST; Heller MB; Hewett D; Moskin LC; Bunning ML; Layton M
    Emerg Infect Dis; 2003 Jun; 9(6):689-96. PubMed ID: 12781008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the true number of victims of the postal anthrax attack of 2001?
    Cymet TC; Kerkvliet GJ
    J Am Osteopath Assoc; 2004 Nov; 104(11):452. PubMed ID: 15602039
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related Anthrax--Connecticut, 2001.
    JAMA; 2002 Jan; 287(1):34-5. PubMed ID: 11797623
    [No Abstract]   [Full Text] [Related]  

  • 16. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention
    JAMA; 2001 Nov; 286(19):2392-6. PubMed ID: 11759667
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.
    Dewan PK; Fry AM; Laserson K; Tierney BC; Quinn CP; Hayslett JA; Broyles LN; Shane A; Winthrop KL; Walks I; Siegel L; Hales T; Semenova VA; Romero-Steiner S; Elie C; Khabbaz R; Khan AS; Hajjeh RA; Schuchat A;
    Emerg Infect Dis; 2002 Oct; 8(10):1066-72. PubMed ID: 12396917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
    Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
    Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responding to a bioterrorist attack: environmental investigation of anthrax in New Jersey.
    Valiante DJ; Schill DP; Bresnitz EA; Burr GA; Mead KR
    Appl Occup Environ Hyg; 2003 Oct; 18(10):780-5. PubMed ID: 12959889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.